has been cited by the following article(s):
[1]
|
GRK5 Deficiency Causes Mild Cognitive Impairment due to Alzheimer’s Disease
Journal of Alzheimer's Disease,
2022
DOI:10.3233/JAD-215379
|
|
|
[2]
|
Recent Advances in the Rational Drug Design Based on Multi-target Ligands
Current Medicinal Chemistry,
2020
DOI:10.2174/0929867327666200102120652
|
|
|
[3]
|
Complex noradrenergic dysfunction in Alzheimer’s disease: Low norepinephrine input is not always to blame
Brain Research,
2018
DOI:10.1016/j.brainres.2018.01.001
|
|
|
[4]
|
GRK5 deficiency leads to susceptibility to intermittent hypoxia-induced cognitive impairment
Behavioural Brain Research,
2016
DOI:10.1016/j.bbr.2016.01.019
|
|
|
[5]
|
GRK5 Deficiency Leads to Selective Basal Forebrain Cholinergic Neuronal Vulnerability
Scientific Reports,
2016
DOI:10.1038/srep26116
|
|
|
[6]
|
G Protein-Coupled Receptor Kinases
Methods in Pharmacology and Toxicology,
2016
DOI:10.1007/978-1-4939-3798-1_10
|
|
|
[7]
|
GRK5 Deficiency Leads to Selective Basal Forebrain Cholinergic Neuronal Vulnerability
Scientific Reports,
2016
DOI:10.1038/srep26116
|
|
|